A treatment pioneered at the University of Pittsburgh Center for Vaccine Research (CVR) is far more effective than traditional antibiotics at inhibiting the growth of drug-resistant bacteria, including so-called “superbugs” resistant to almost all existing antibiotics, which plague hospitals and nursing homes.
The findings, announced online in the journal Antimicrobial Agents and Chemotherapy and funded by the National Institutes of Health, provide a needed boost to the field of antibiotic development, which has been limited in the last four decades and outpaced by the rise of drug-resistant bacterial strains.
“Very few, if any, medical discoveries have had a larger impact on modern medicine than the discovery and development of antibiotics,” said senior author Ronald C. Montelaro, Ph.D., professor and co-director of Pitt’s CVR. “However, the success of these medical achievements is being threatened due to increasing frequency of antibiotic resistance. It is critical that we move forward with development of new defenses against the drug-resistant bacteria that threaten the lives of our most vulnerable patients.”
Each year in the U.S., at least 2 million people are infected with drug-resistant bacteria, and at least 23,000 die as a direct result of these infections, according to the U.S. Centers for Disease Control and Prevention.
On the tail end of HIV surface protein, there is a sequence of amino acids that the virus uses to “punch into” and infect cells. Dr. Montelaro and his colleagues developed a synthetic and more efficient version of this sequence – called engineered cationic antimicrobial peptides, or “eCAPs”—that can be chemically synthesized in a laboratory setting.< The team tested the two leading eCAPs against a natural antimicrobial peptide (LL37) and a standard antibiotic (colistin), the latter being used as a last-resort antibiotic against multidrug resistant bacterial infections. The scientists performed the tests in a laboratory setting using 100 different bacterial strains isolated from the lungs of pediatric cystic fibrosis patients of Seattle Children’s Hospital and 42 bacterial strains isolated from hospitalized adult patients at UPMC.
The natural human antimicrobial peptide LL37 and the colistin drug each inhibited growth of about 50 percent of the clinical isolates, indicating a high level of bacterial resistance to these drugs. In marked contrast, the two eCAPS inhibited growth in about 90 percent of the test bacterial strains.
The Latest on: Antibiotic-Resistant Superbugs
[google_news title=”” keyword=”Antibiotic-Resistant Superbugs” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antibiotic-Resistant Superbugs
- Breakthrough Vaccine Shows High Protection Against Drug-Resistant Superbug in Miceon April 26, 2024 at 4:03 pm
Scientists have developed a vaccine against a notorious drug-resistant superbug, targeting molecules on its surface that are also found on other bacteria and fungi.
- Superbug from human eye drops outbreak spread to dogson April 26, 2024 at 11:19 am
The discovery of drug-resistant bacteria in two dogs prompted a probe by the CDC and New Jersey health authorities.
- Superbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistanceon April 25, 2024 at 5:25 pm
Uncontrolled AMR is also projected to cost the world $855 billion annually until 2035, international leaders say.
- Climate change fuels the rise of global antimicrobial resistanceon April 25, 2024 at 10:34 am
Climate change exacerbates antimicrobial resistance by altering environments where microbes thrive, leading to increased disease spread.
- Artificial Intelligence Help Prevent Superbugson April 24, 2024 at 12:50 pm
AI successfully devised highly efficient antibiotic cycling strategies for treating multiple strains of E. coli, effectively thwarting drug resistance.
- Commission approves superbug-busting antibioticon April 22, 2024 at 5:29 am
The European Commission today (22 April) authorised a new antibiotic designed to counter anti-bacterial resistance, one of the biggest health threats the EU is currently facing.
- Warning to all cat and dog owners over 'superbug' spreading to humans and it's antibiotic-resistanton April 20, 2024 at 3:17 am
The antibiotic-resistant bacteria can be passed between sick pets and their healthy owners in Britain, Portuguese researchers found ...
- Cats and dogs are spreading dangerous antibiotic-resistant ‘superbugs’ to their owners, study findson April 19, 2024 at 2:01 pm
DOGS and cats are spreading drug-resistant “superbugs” to their owners, a study suggests. The antibiotic-resistant bacteria can be passed between sick pets and their healthy owners in Britain, ...
- Pets pass antibiotic-resistant 'superbugs' to humanson April 15, 2024 at 7:45 am
Dogs and cats can pass antibiotic-resistant bacteria to their owners, raising concerns that household pets could be contributing to the world's antibiotics crisis, a new study says.
- Warning As Dogs and Cats May Pass 'Superbugs' Onto Pet Ownerson April 15, 2024 at 6:33 am
The findings challenge the widely held belief that humans are the main carriers of antimicrobial-resistant bacteria in the community.
via Bing News